Berlin - Delayed Quote EUR

Annovis Bio Inc (07X.BE)

Compare
2.5250
+0.0800
+(3.27%)
As of 11:02:16 AM GMT+1. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
30,402.3800
45,035.0110
25,511.2790
14,500.4670
5,482.7720
Operating Income
-30,402.3800
-45,035.0110
-25,511.2790
-14,500.4670
-5,482.7720
Net Non Operating Interest Income Expense
-1,598.4220
667.8980
182.7120
13.3350
47.2250
Other Income Expense
--
-11,837.2000
--
--
-26.5000
Pretax Income
-40,939.1100
-56,204.3130
-25,328.5670
-14,487.1320
-5,462.0470
Net Income Common Stockholders
-40,939.1100
-56,204.3130
-25,328.5670
-14,487.1320
-5,462.0470
Diluted NI Available to Com Stockholders
-40,939.1100
-56,204.3130
-25,328.5670
-14,487.1320
-5,462.0470
Basic EPS
-3.97
-6.23
-3.10
-1.90
-0.87
Diluted EPS
-4.22
-6.23
-3.10
-1.90
-0.87
Basic Average Shares
11,027.2960
9,023.1380
8,162.3260
7,626.2780
6,308.9610
Diluted Average Shares
11,077.2230
9,023.1380
8,162.3260
7,626.2780
6,308.9610
Total Operating Income as Reported
-30,402.3800
-45,035.0110
-25,511.2790
-14,537.2210
-6,640.2210
Total Expenses
30,402.3800
45,035.0110
25,511.2790
14,500.4670
5,482.7720
Net Income from Continuing & Discontinued Operation
-40,939.1100
-56,204.3130
-25,328.5670
-14,487.1320
-5,462.0470
Normalized Income
-32,000.8020
-44,367.1130
-25,328.5670
-14,487.1320
-5,435.5470
Interest Income
271.7060
667.8980
182.7120
13.3350
47.2250
Net Interest Income
-1,598.4220
667.8980
182.7120
13.3350
47.2250
EBIT
-30,402.3800
-45,035.0110
-25,511.2790
-14,500.4670
-5,482.7720
EBITDA
-30,402.3800
-45,035.0110
-25,511.2790
-14,500.4670
-5,482.7720
Net Income from Continuing Operation Net Minority Interest
-40,939.1100
-56,204.3130
-25,328.5670
-14,487.1320
-5,462.0470
Total Unusual Items Excluding Goodwill
-8,938.3080
-11,837.2000
--
--
-26.5000
Total Unusual Items
-8,938.3080
-11,837.2000
--
--
-26.5000
Normalized EBITDA
-21,464.0720
-33,197.8110
-25,511.2790
-14,500.4670
-5,456.2720
12/31/2020 - 7/9/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AAVXF ABIVAX Société Anonyme
5.89
0.00%
 
DBV.PA DBV Technologies S.A.
0.8480
+4.55%
 
TECX Tectonic Therapeutic, Inc.
31.60
-0.85%
 
DYN Dyne Therapeutics, Inc.
13.92
+2.96%
 
BCTX BriaCell Therapeutics Corp.
3.7800
+10.20%
 
VLA.PA Valneva SE
3.7200
-4.08%
 
AVXL Anavex Life Sciences Corp.
8.70
+4.95%
 
RNAZ TransCode Therapeutics, Inc.
10.78
-0.46%
 
OCEA Ocean Biomedical, Inc.
0.1738
-13.10%